0001209191-23-059055.txt : 20231218
0001209191-23-059055.hdr.sgml : 20231218
20231218201705
ACCESSION NUMBER: 0001209191-23-059055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Charlton Ralph William III
CENTRAL INDEX KEY: 0001919397
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 231495331
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BOULEVARD, SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 740
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (415) 655-4168
MAIL ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 740
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-14
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001919397
Charlton Ralph William III
C/O SPRUCE BIOSCIENCES, INC.
611 GATEWAY BOULEVARD, SUITE 740
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-12-15
4
M
0
31750
0.00
A
56992
D
Common Stock
2023-12-15
4
F
0
10980
1.66
D
46012
D
Restricted Stock Units
0.00
2023-12-14
4
A
0
212800
0.00
A
Common Stock
212800
212800
D
Restricted Stock Units
0.00
2023-12-15
4
M
0
31750
0.00
D
Common Stock
31750
95250
D
On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares.
Each RSU represents a contingent right to receive one share of SPRB common stock.
106,400 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
106,400 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
Represents the aggregate balance of 95,250 time-based RSUs.
/s/ Samir M. Gharib, Attorney-in-Fact
2023-12-18